Adverse outcome of T3-predominant maternal Grave's disease during pregnancy in the mother and the offspring

Endokrynol Pol. 2023;74(3):340-341. doi: 10.5603/EP.a2023.0031. Epub 2023 May 8.

Authors

Aleksandra Mikołajczak¹, Renata Bokiniec², Agnieszka Sienicka³, Agata Pisula³, Ewa Romejko-Wolniewicz⁴

Affiliations

¹ Neonatal Department, Collegium Medicum of Cardinal Stefan Wyszynski University, Warsaw, Poland.
² Neonatal and Intensive Care Department, Medical University of Warsaw, Warsaw, Poland.
³ Students' Scientific Group affiliated to the 2nd Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland.
⁴ 2nd Department of Obstetrics and Gynaecology, Medical University of Warsaw, Warsaw, Poland. ewa.romejko-wolniewicz@wum.edu.pl.

PMID: 37155306
DOI: 10.5603/EP.a2023.0031

Abstract

Note required for Clinical Vignette.

Keywords: T3-predominant Grave’s disease; hyperthyroidism; neonatal; pregnancy.

MeSH terms

Female
Graves Disease*
Humans
Mothers*
Pregnancy